Therapeutic potential of recombinant p53 overexpression in breast cancer cells expressing endogenous wild-type p53

Breast Cancer Research and Treatment

Volumn 48, Issue 3, 1998, Pages 273-286

  Li, Peixiang ^b   Bui, Thuy ^b   Gray, Dawn ^b   Klamut, Henry J ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b NONE

Author keywords

Adenoviral vectors; Apoptosis; Breast cancer; Gene therapy; p53

Indexed keywords

GANCICLOVIR; PROTEIN P53; RECOMBINANT PROTEIN; THYMIDINE KINASE;

ADENOVIRUS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE G1 PHASE; CELL DEATH; CELL STRAIN MCF 7; CELL VIABILITY; CYTOTOXICITY; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; APOPTOSIS; BREAST NEOPLASMS; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031897756     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005961705860     Document Type: Article

References (50)

1. Beaudry GA, Bertelsen AH, Sherman MI: Therapeutic targeting of the p53 tumor suppressor gene. [Review.] Curr Opin Biotechnol 7: 592-600, 1996
2. Su N, Ojeifo JO, MacPherson A, Zwiebel JA: Breast cancer gene therapy: transgenic immunotherapy. [Review.] Breast Cancer Res Treat 31: 349-356, 1994
3. Harris AL, Fox S, Bicknell R, Leek R, Relf M, LeJeune S, Kuklamanis L: Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer. [Review.] Cancer 74: 1021-1025, 1994
4. Martin S.I. Green DR: Apoptosis as a goal of cancer therapy. [Review.] Curr Opin Oncol 6: 616-621, 1994
5. Martin SJ. Green DR: Apoptosis and cancer: the failure of controls on cell death and cell survival. [Review.] Crit Rev Oncol-Hematol 18: 137-153, 1995
6. Kovach JS, Hartmann A, Blaszyk H, Cunningham J, Schaid D, Sommer SS: Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc Natl Acad Sci USA 93: 1093-1096, 1996
7. Norberg T, Jansson T, Sjogren S, Martensson C, Andreasson I, Fjallskog ML, Lindman H, Nordgren H, Lindgren A, Holmberg L, Bergh J: Overview on human breast cancer with focus on prognostic and predictive factors with special attention on the tumor suppressor gene p53. [Review.] Acta Oncol 35 (5): 96-102, 1996
8. Bergh J, Norberg T, Sjogren S, Lindgren A, Holmberg L: Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med 1: 1029-1034, 1995
9. Elledge RM, Allred DC: The p53 tumor suppressor gene in breast cancer. [Review.] Breast Cancer Res Treat 32: 39-47, 1994
10. Vogelstein B: Cancer. A deadly inheritance [news; comment]. Nature 348: 681-682, 1990
11. Harris CC: Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. [Review.] J Natl Cancer Inst 88: 1442-1455, 1996
12. Kinzler KW, Vogelstein B: Cancer therapy meets p53 [see comments]. N Engl J Med 331: 49-50, 1994
13. Wyllie AH, Carder PJ, Clarke AR, Cripps KJ, Gledhill S, Greaves MF, Griffiths S, Harrison DJ, Hooper ML, Morris RG et al.: Apoptosis in carcinogenesis: the role of p53. Cold Spring Harbor Symp Quant Biol 59: 403-409, 1994
14. Casey G, Lo-Hsueh M, Lopez ME, Vogelstein B, Stanbridge EJ: Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene 6: 1791-1797, 1991
15. Wills KN, Maneval DC, Menzel P, Harris MP, Sutjipto S, Vaillancourt MT, Huang WM Johnson DE, Anderson SC, Wen SF et al.: Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum Gene Ther 5: 1079-1088, 1994
16. Katayose D, Gudas J, Nguyen H, Srivastava S, Cowan K, Seth P: Cytotoxic effects of adenovirus-mediated wild type p53 protein expression in normal and tumor mammary epithelial cells. Clin Cancer Res 1: 889-897, 1995
17. Li P, Klamut HJ: Differential chemosensitivity of breast cancer cells to gancyclovir treatment following adenovirus-mediated HSVtk-gene transfer. (submitted), 1998.
18. Celis A, Celis JE: General procedures for tissue culture. In: Celis JE (ed) Cell Biology: A Laboratory Handbook. Academic Press, San Diego, 1994
19. Graham FL, Prevec L: Methods for construction of adenovirus vectors. Mol Biotechnol 3: 207-220, 1995
20. Zhang WW, Koch PE, Roth JA: Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. Biotechniques 18: 444-447, 1995
21. Zhang WW, Alemany R, Wang J, Koch PE, Ordonez NG, Roth JA: Safety evaluation of Ad5CMV-p53 in vitro and in vivo. Hum Gene Ther 6: 155-164, 1995
22. Brezden CB, Rauth AM: Differential cell death in immortalized and non-immortalized cells at confluency. Oncogene 12: 201-206, 1996
23. Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne VL, Culhane AC, Williams GT: Apoptosis: molecular regulation of cell death [published erratum appears in Eur J Biochem 1996 May 1: 237 (3): 884]. [Review.] Eur J Biochem 236: 1-26, 1996
24. Spencer SJ, Cataldo NA, Jaffe RB: Apoptosis in the human female reproductive tract. [Review.] Obst Gynecol Surv 51: 314-323, 1996
25. Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh JE: Active cell death in hormone-dependent tissues. [Review.] Cancer Metas Rev 11: 197-220, 1992
26. Yonish-Rouach E: The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis. [Review.] Experientia 52: 1001-1007, 1996
27. Meyn RE, Stephens LC, Mason KA, Medina D: Radiation-induced apoplosis in normal and pre-neoplastic mammary glands in vivo: significance of gland differentiation and p53 status. Internatl J Cancer 65: 466-472, 1996
28. Lowe SW, Ruley HE, Jacks T, Housman DE:p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993
29. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes [see comments]. Nature 362: 847-849, 1993
30. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways [see comments]. Nature 362: 849-852, 1993
31. Merlo GR, Basolo F, Fiore L, Duboc L, Hynes NE: p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J Cell Biol 128: 1185-1196, 1995
32. Aas T, Borresen AL, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug JE, Akslen LA, Lonning PE: Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 2: 811-814, 1996
33. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993
34. Fan S, Smith ML, Rivet DJ, Duba D, Zhan Q, Kohn KW, Fornace AJ Jr, O'Connor PM: Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 55: 1649-1654, 1995
35. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299, 1995
36. Miyashita T, Harigai M, Hanada M, Reed JC: Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54: 3131-3135, 1994
37. Silvestrini R, Benini E, Veneroni S, Daidone MG, Tomasic G, Squicciarini P, Salvadori B: p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients. J Clin Oncol 14: 1604-1610, 1996
38. Bargou RC, Daniel PT, Mapara MY, Bommert K, Wagener C, Kallinich B, Royer HD, Dorken B: Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 60: 854-859, 1995
39. Joensuu H, Pylkkanen L, Toikkanen S: Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145: 1191-1198, 1994
40. Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, Nordling S, Reed JC: Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55: 4471-4478, 1995
41. Teixeira C, Reed JC, Pratt MA: Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55: 3902-3907, 1995
42. Sumantran VN, Ealovega MW, Nunez G, Clarke MF, Wicha MS: Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res 55: 2507-2510, 1995
43. Canman CE, Gilmer TM, Coutts SB, Kastan MB: Growth factor modulation of p53-mediated growth arrest versus apoptosis. Gen Dev 9: 600-611, 1995
44. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ: Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270: 96-99, 1995
45. Schott AF, Apel IJ, Nunez G, Clarke MF: Bcl-XL protects cancer cells from p53-mediated apoptosis. Oncogene 11: 1389-1394, 1995
46. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608, 1993
47. Ealovega MW, McGinnis PK, Sumantran VN, Clarke MF, Wicha MS: bcl-xs gene therapy induces apoptosis of human mammary tumors in nude mice. Cancer Res 56: 1965-1969, 1996
48. Clarke MF, Apel IJ, Benedict MA, Eipers PG, Sumantran V, Gonzalez-Garcia M, Doedens M, Fukunaga N, Davidson B, Dick JE et al.: A recombinant bcl-xs adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc Natl Acad Sci USA 92: 11024-11028, 1995
49. Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ: In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 55: 1-6, 1995
50. Drazan KE, Shen XD, Csete ME, Zhang WW, Roth JA, Busuttil RW, Shaked A: In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection. Surgery 116: 197-203, 1994